These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 12496946)

  • 1. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
    Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
    Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice.
    Ralph-Williams RJ; Lehmann-Masten V; Otero-Corchon V; Low MJ; Geyer MA
    J Neurosci; 2002 Nov; 22(21):9604-11. PubMed ID: 12417685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do D1/D2 interactions regulate prepulse inhibition in rats?
    Wan FJ; Taaid N; Swerdlow NR
    Neuropsychopharmacology; 1996 Apr; 14(4):265-74. PubMed ID: 8924194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
    Ralph RJ; Caine SB
    J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.
    Bortolato M; Aru GN; Fà M; Frau R; Orrù M; Salis P; Casti A; Luckey GC; Mereu G; Gessa GL
    Neuropsychopharmacology; 2005 Mar; 30(3):561-74. PubMed ID: 15328529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat.
    Caine SB; Geyer MA; Swerdlow NR
    Neuropsychopharmacology; 1995 Apr; 12(2):139-45. PubMed ID: 7779242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of dopamine D1, D2, and D3 receptor subtypes to the disruptive effects of cocaine on prepulse inhibition in mice.
    Doherty JM; Masten VL; Powell SB; Ralph RJ; Klamer D; Low MJ; Geyer MA
    Neuropsychopharmacology; 2008 Oct; 33(11):2648-56. PubMed ID: 18075489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
    Auclair AL; Kleven MS; Besnard J; Depoortère R; Newman-Tancredi A
    Neuropsychopharmacology; 2006 Sep; 31(9):1900-9. PubMed ID: 16421514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine agonist-induced hypothermia and disruption of prepulse inhibition: evidence for a role of D3 receptors?
    Varty GB; Higgins GA
    Behav Pharmacol; 1998 Sep; 9(5-6):445-55. PubMed ID: 9832930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of dopamine in prepulse inhibition of acoustic startle.
    Zhang J; Forkstam C; Engel JA; Svensson L
    Psychopharmacology (Berl); 2000 Apr; 149(2):181-8. PubMed ID: 10805614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat.
    Swerdlow NR; Keith VA; Braff DL; Geyer MA
    J Pharmacol Exp Ther; 1991 Feb; 256(2):530-6. PubMed ID: 1825226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of haloperidol and SCH 23390 on acoustic startle and prepulse inhibition under basal and stimulated conditions.
    Schwarzkopf SB; Bruno JP; Mitra T
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Nov; 17(6):1023-36. PubMed ID: 8278596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selective dopamine D1-like and D2-like agonists on prepulse inhibition of startle in inbred C3H/HeJ, SPRET/EiJ, and CAST/EiJ mice.
    Ralph RJ; Caine SB
    Psychopharmacology (Berl); 2007 Apr; 191(3):731-9. PubMed ID: 17019570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44.
    Weber M; Chang WL; Durbin JP; Park PE; Luedtke RR; Mach RH; Swerdlow NR
    Pharmacol Biochem Behav; 2009 Aug; 93(2):141-7. PubMed ID: 19426754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
    Gogos A; Kwek P; Chavez C; van den Buuse M
    J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation.
    Weber M; Chang WL; Breier M; Ko D; Swerdlow NR
    Behav Pharmacol; 2008 Dec; 19(8):786-95. PubMed ID: 19020413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventral hippocampal dopamine D1 and D2 systems and spatial working memory in rats.
    Wilkerson A; Levin ED
    Neuroscience; 1999 Mar; 89(3):743-9. PubMed ID: 10199609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists.
    Ralph RJ; Paulus MP; Fumagalli F; Caron MG; Geyer MA
    J Neurosci; 2001 Jan; 21(1):305-13. PubMed ID: 11150348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia.
    Peng RY; Mansbach RS; Braff DL; Geyer MA
    Neuropsychopharmacology; 1990 Jun; 3(3):211-8. PubMed ID: 2141986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.
    Frau R; Mosher LJ; Bini V; Pillolla G; Pes R; Saba P; Fanni S; Devoto P; Bortolato M
    Psychoneuroendocrinology; 2016 Jan; 63():59-67. PubMed ID: 26415119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.